Over $855K in MCD (NYSE: MCD) stock planned for insider sale

Rhea-AI Filing Summary

A person associated with the issuer filed a Form 144 notice to sell 2,626 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of 855,025.60 on the NYSE.

The shares to be sold were acquired on 02/10/2026 by exercising stock options for cash. The filer also reports prior sales in the last three months, including 2,626 shares sold on 01/12/2026 under a Rule 10b5-1 plan for gross proceeds of 805,068.58 and 3,195 shares sold on 11/14/2025 for gross proceeds of 977,094.90.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2626	855025.60	712154350	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Exercise of Stock Options	Issuer			2626	02/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	01/12/2026	2626	805068.58
JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	11/14/2025	3195	977094.90

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing indicate for MCD?

The filing shows a planned sale of 2,626 common shares by a person associated with the issuer. The shares were acquired via stock option exercise and will be sold through Morgan Stanley Smith Barney on the NYSE, with reported market value of 855,025.60.

How many MCD shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 2,626 common shares. These shares were obtained on 02/10/2026 by exercising stock options for cash and are listed with an aggregate market value of 855,025.60 for sale on the NYSE.

What prior MCD stock sales are disclosed in this Form 144?

The filing reports two prior sales in the past three months. On 01/12/2026, 2,626 shares were sold under a Rule 10b5-1 plan for 805,068.58, and on 11/14/2025, 3,195 shares were sold for 977,094.90.

Who is identified in the Form 144 transactions related to MCD?

The document references “10b5-1 Sales for JOSEPH ERLINGER” for a sale on 01/12/2026 and a separate sale by “JOSEPH ERLINGER” on 11/14/2025. Both involve common stock sales with detailed share counts and gross proceeds.

How were the MCD shares in this Form 144 acquired?

The 2,626 shares covered by the notice were acquired on 02/10/2026 through an exercise of stock options from the issuer. The form notes the acquisition was paid in cash on the same date before the planned NYSE sale.